| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/13/2010 | CN101623501A Long-acting protein medicament and preparation method thereof |
| 01/13/2010 | CN101623500A Application of oil emulsion adjuvant |
| 01/13/2010 | CN100580006C Synthesis process for polyglycol modifier of benzoic acid/nitrobenzoic acid |
| 01/13/2010 | CN100579577C Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 01/13/2010 | CN100579576C Entoptic embedding material for preventing aggravation of nearsightedness |
| 01/13/2010 | CN100579567C Use of Chinese medicine preparation in preparing medicine for defending coronary heart disease |
| 01/13/2010 | CN100579566C Chinese-medicinal coated tablets for treating gynecological and preparation thereof |
| 01/13/2010 | CN100579536C Preparation method for graininess medicine containing hirsutella hepia - cordyceps fungus powder |
| 01/13/2010 | CN100579530C Stabilized compositions comprising therapeutically active agent, citric acid or conjugated base and chlorine dioxide |
| 01/13/2010 | CN100579528C Dispersion tablet for improving brain circulation |
| 01/13/2010 | CN100579525C Sustained release preparation of licardipine hydrochloride and its preparing process |
| 01/13/2010 | CN100579524C Method of preparing simvastatin sustained-release microsphere carried series |
| 01/13/2010 | CN100579523C Dihydroartemisinin emulsion for injection, freeze-dried emulsion and preparation method thereof |
| 01/13/2010 | CN100579522C Pasting agent |
| 01/13/2010 | CN100579516C Vaginal effervescence tablet composition containing solid lipid |
| 01/13/2010 | CN100579514C Method for preparing particles through controlled agglomeration and method for increasing bioavailability |
| 01/13/2010 | CN100579513C Preparation method of lung targeting emodin polylactic acid microsphere |
| 01/13/2010 | CN100579512C Method of producing water-solubility hypocrellin titanium dioxide nano granule |
| 01/13/2010 | CN100579510C Precursor micelle preparation and its production process |
| 01/13/2010 | CN100579508C Oral-cleaning orally disintegrating tablet and preparing technique thereof |
| 01/12/2010 | US7645816 Water-soluble compositions of bioactive lipophilic compounds |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645793 Effective ingredient and basic agent; foam suppression |
| 01/12/2010 | US7645765 With water miscible solubilizer; phosphodiesterase inhibitors; cardiovascular disorders |
| 01/12/2010 | US7645747 Improved pharmacokinetic properties, oral bioavailability; side effect reduction |
| 01/12/2010 | US7645736 injecting an alpha-v. beta 3 or alpha-v, beta 5 inhibitor into the vitreous body of the eye; angiogenesis inhibition; diabetic retinopathy, macular degeneration, myopia, ocular histoplasmosis; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 01/12/2010 | US7645595 Culturing epidermal keratinocytes on collagen gel layer containing human fibroblasts, exposing to air, and culture contains matrix metalloproteinase inhibitor such as N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride |
| 01/12/2010 | US7645468 Oil seed meal preparation |
| 01/12/2010 | CA2545878C Compositions and methods for treating a posterior segment of an eye |
| 01/12/2010 | CA2442906C Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2427467C Sn-38 lipid complexes and methods of use |
| 01/12/2010 | CA2407298C Mixtures of triblock polyesterpolyethylene glycol copolymers |
| 01/12/2010 | CA2373936C Nasogastric enteral formulations |
| 01/12/2010 | CA2346170C Site-specific labeling of disulfide-containing targeting vectors |
| 01/12/2010 | CA2309604C Compositions and methods for targeted delivery of factors |
| 01/12/2010 | CA2144674C Use of azoles as virucidal agents in solutions of biologically active proteins |
| 01/07/2010 | WO2010003009A2 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 01/07/2010 | WO2010002965A2 Pneumonia treatment |
| 01/07/2010 | WO2010002473A1 Unit dosage of apadenoson |
| 01/07/2010 | WO2010002450A2 Micelles for delivery of nitric oxide |
| 01/07/2010 | WO2010001933A1 Histone modification inhibitor specific to target gene |
| 01/07/2010 | WO2010001932A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | WO2010001926A1 Water-containing composition |
| 01/07/2010 | WO2010001671A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle devive |
| 01/07/2010 | WO2010001574A1 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 01/07/2010 | WO2010001267A2 Delivery product for topical compositions |
| 01/07/2010 | WO2010000869A1 A macrocyclic derivative and assemblies formed therefrom |
| 01/07/2010 | WO2010000740A1 Pharmaceutical dosage form comprising polymeric carrier composition |
| 01/07/2010 | WO2010000565A1 Method for diagnosing cancers expressing the her2 receptor or its truncated variants |
| 01/07/2010 | WO2009138473A3 Intracellular antibody delivery |
| 01/07/2010 | WO2009129494A3 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 01/07/2010 | WO2009129336A3 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections |
| 01/07/2010 | WO2009129155A3 Dexamethasone formulations in a biodegradable material |
| 01/07/2010 | WO2009126805A3 Therapeutic tarageting of mmps in neutral liposomes |
| 01/07/2010 | WO2009122431A3 Oral controlled release tablet with reduced burst effect |
| 01/07/2010 | WO2009117041A3 Use of pyrene to carry peptides across the blood brain barrier |
| 01/07/2010 | WO2009115175A3 Lyophilized nanoemulsion |
| 01/07/2010 | WO2009088549A3 Methods of inhibiting bacterial virulence and compounds relating thereto |
| 01/07/2010 | WO2009076105A3 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 01/07/2010 | WO2008099397A3 Compositions and methods for enhancing transmucosal delivery |
| 01/07/2010 | WO2008087647A3 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle) |
| 01/07/2010 | US20100004628 System for delivering a composition to the nasal membrane and method of using same |
| 01/07/2010 | US20100004424 Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof |
| 01/07/2010 | US20100004390 Biodegradable metal-chelating polymers and vaccines |
| 01/07/2010 | US20100004345 High gloss non-stick film coating compositions |
| 01/07/2010 | US20100004336 comprising L-lysine-d-amphetamine hydrochloride salt; without spiking blood serum concentrations of amphetamine; sustained release; for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability; reducing oral abuse liability |
| 01/07/2010 | US20100004276 Vitamin receptor binding drug delivery conjugates |
| 01/07/2010 | US20100003340 Cosmetic compositions for the treatment of skin and methods thereof |
| 01/07/2010 | US20100003337 Functionalized poly(ether-anhydride) block copolymers |
| 01/07/2010 | US20100003327 Bioabsorbable Polymeric Composition for a Medical Device |
| 01/07/2010 | US20100003320 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/07/2010 | US20100003312 External skin patch |
| 01/07/2010 | US20100003304 Method of improving the osteoinductivity of calcium phosphate |
| 01/07/2010 | US20100003280 Adjuvant compositions |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | CA2729819A1 Unit dosage of apadenoson |
| 01/07/2010 | CA2729775A1 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2729749A1 Tnf-a antagonist multi-target binding proteins |
| 01/07/2010 | CA2729582A1 Particles containing an opioid receptor antagonist and methods of use |
| 01/07/2010 | CA2729404A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device |
| 01/07/2010 | CA2729148A1 Pharmaceutical dosage form comprising polymeric carrier composition |
| 01/07/2010 | CA2728762A1 Rna antagonists targeting hsp27 |
| 01/07/2010 | CA2727365A1 Method for diagnosing cancers expressing the her2 receptor or its truncated variants |
| 01/07/2010 | CA2726538A1 Foam skin care cream |
| 01/06/2010 | EP2140883A1 Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion |
| 01/06/2010 | EP2140882A1 Agent for treatment of pulmonary disease |
| 01/06/2010 | EP2140877A1 New use of coccidian |
| 01/06/2010 | EP2140871A1 Suspension for visualization of transparent tissue in eye |
| 01/06/2010 | EP2140870A1 Prompt nucleic acid delivery carrier composition |
| 01/06/2010 | EP2140867A1 Pharmaceutical composition |
| 01/06/2010 | EP2140861A1 Pharmaceutical dosage form comprising polymeric carrier composition |
| 01/06/2010 | EP2140005A1 Antagonists of ligands and uses thereof |
| 01/06/2010 | EP2139531A1 Carriers for drug delivery |
| 01/06/2010 | EP2139526A1 Novel formulations for delivery of antiviral peptide therapeutics |
| 01/06/2010 | EP2139525A1 Fusion protein capable of degrading amyloid beta peptide |
| 01/06/2010 | EP2139524A1 Multivalent heterobifunctional polymers and methods of their use |
| 01/06/2010 | EP2139523A2 Binding ligand linked drug delivery conjugates of tubulysins |
| 01/06/2010 | EP2139522A2 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |